Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 57,180 shares at $14.13 ($798K) on 2026-04-22, disclosed to the SEC on 2026-04-24.
Scheduled sale ($798k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.13 | 19,060 | $269K | 33.7% |
| 2 | $13.74 | 19,060 | $262K | 32.8% |
| 3 | $14.02 | 19,060 | $267K | 33.5% |
| Total | $13.96 avg | 57,180 | $798K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-08 | $948K | — | Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |